Weibin Wang

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersComputational physiologyCancer diagnosisHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 30, 2026
BRAF Mutation Status Determines the Prognostic Value of Tumor Bilaterality in Papillary Thyroid Carcinoma: A Retrospective Cohort Study.

|Mar 21, 2026
Fatty acid oxidation drives acetyl-CoA-dependent H3K9ac reprogramming to promote adaptive resistance to BRAFV600E inhibition in thyroid cancer.

Xumeng Wang, Jing Zhang, Jimeng Yuan

|Aug 20, 2025
Independent Clonal Origin in Early-Stage Bilateral Papillary Thyroid Cancer: Evidence From Nuclear and Mitochondrial Genome Analysis.

Xingyun Su, Jimeng Yuan, Xianmeng Chen

|Aug 30, 2024
Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid Cancer.

Jimeng Yuan, Zhendong Chen, Jing Zhang

|May 15, 2023
BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation.

Xumeng Wang, Tianxing Ying, Jimeng Yuan

|Feb 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.

Jessica Limberg, Caitlin E Egan, Katherine D Gray

Pageof 2

Frequent Collaborators

3 joint publications

Lisong Teng

2 joint publications

Yongfeng Ding

2 joint publications

Lisong Teng

1 joint publications

Zhuochao Mao